Drawing for Serial No. 79439659

USPTO serial 79439659

Serial No. 79439659

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BLAZICH, JOAN MICHELE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with Serial No. 79439659?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Justin Brown

Justin Brown Brown Brothers Law LLP1827 harley driveann arbor, MI 48103United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for diagnosing infectious diseases, early stage pregnancy and tumors; chemico-pharmaceutical preparations for treating HIV, Hepatitis B (HBV), Hepatitis C (HCV), Hepatitis A (HAV), Helicobacter pylori infection (H. pylori), Dengue, and Syphilis; drugs for medical purposes, namely, pharmaceutical preparations for treating HIV, Hepatitis B (HBV), Hepatitis C (HCV), Hepatitis A (HAV), Helicobacter pylori infection (H. pylori), Dengue, and Syphilis; preparations of microorganisms for medical or veterinary use; biological preparations for use in cell cultures for medical purposes; chemical preparations for pharmaceutical purposes, namely, for pregnancy testing, tumor testing, infectious disease testing, cardiovascular disease testing, drug testing and immune disease testing; chemical preparations for medical purposes, namely, for pregnancy testing, tumor testing, infectious disease testing, cardiovascular disease testing, drug testing and immune disease testing; chemical preparations for the diagnosis of pregnancy; cultures of microorganisms for medical or veterinary use; diagnostic preparations for medical purposesACTIVE—
010Surgical apparatus and instruments; fitted medical instrument cases for use by doctors; medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; cases fitted for medical instruments; apparatus for use in medical analysis, namely, analysing and identifying body fluids; diagnostic apparatus for medical purposes, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; galvanic therapeutic appliances, namely, apparatus for magnet therapy; physiotherapy apparatus, namely, foam rollersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 29, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 29, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 23, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 3, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 2, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 2, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Sep 2, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 2, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 11, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 11, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 11, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 5, 2026RFNTREFUSAL PROCESSED BY IB—
Feb 14, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 14, 2026RFRRREFUSAL PROCESSED BY MPU—
Feb 5, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 17, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 16, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 12, 2026DOCKASSIGNED TO EXAMINER—
Jan 8, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 8, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 18, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance